BMS-986447
- Generic Name
- BMS-986447
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986447 in Healthy Participants
- First Posted Date
- 2023-03-09
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 32
- Registration Number
- NCT05760937
- Locations
- 🇺🇸
Local Institution - 0001, Anaheim, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath